Alternative genomic diagnoses for individuals with a clinical diagnosis of Dubowitz syndrome
© 2020 Wiley Periodicals LLC..
Dubowitz syndrome (DubS) is considered a recognizable syndrome characterized by a distinctive facial appearance and deficits in growth and development. There have been over 200 individuals reported with Dubowitz or a "Dubowitz-like" condition, although no single gene has been implicated as responsible for its cause. We have performed exome (ES) or genome sequencing (GS) for 31 individuals clinically diagnosed with DubS. After genome-wide sequencing, rare variant filtering and computational and Mendelian genomic analyses, a presumptive molecular diagnosis was made in 13/27 (48%) families. The molecular diagnoses included biallelic variants in SKIV2L, SLC35C1, BRCA1, NSUN2; de novo variants in ARID1B, ARID1A, CREBBP, POGZ, TAF1, HDAC8, and copy-number variation at1p36.11(ARID1A), 8q22.2(VPS13B), Xp22, and Xq13(HDAC8). Variants of unknown significance in known disease genes, and also in genes of uncertain significance, were observed in 7/27 (26%) additional families. Only one gene, HDAC8, could explain the phenotype in more than one family (N = 2). All but two of the genomic diagnoses were for genes discovered, or for conditions recognized, since the introduction of next-generation sequencing. Overall, the DubS-like clinical phenotype is associated with extensive locus heterogeneity and the molecular diagnoses made are for emerging clinical conditions sharing characteristic features that overlap the DubS phenotype.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:185 |
|---|---|
| Enthalten in: |
American journal of medical genetics. Part A - 185(2021), 1 vom: 01. Jan., Seite 119-133 |
| Sprache: |
Englisch |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 29.06.2021 Date Revised 02.04.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1002/ajmg.a.61926 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM316671843 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM316671843 | ||
| 003 | DE-627 | ||
| 005 | 20240402232354.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1002/ajmg.a.61926 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1360.xml |
| 035 | |a (DE-627)NLM316671843 | ||
| 035 | |a (NLM)33098347 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Dyment, David A |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Alternative genomic diagnoses for individuals with a clinical diagnosis of Dubowitz syndrome |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 29.06.2021 | ||
| 500 | |a Date Revised 02.04.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2020 Wiley Periodicals LLC. | ||
| 520 | |a Dubowitz syndrome (DubS) is considered a recognizable syndrome characterized by a distinctive facial appearance and deficits in growth and development. There have been over 200 individuals reported with Dubowitz or a "Dubowitz-like" condition, although no single gene has been implicated as responsible for its cause. We have performed exome (ES) or genome sequencing (GS) for 31 individuals clinically diagnosed with DubS. After genome-wide sequencing, rare variant filtering and computational and Mendelian genomic analyses, a presumptive molecular diagnosis was made in 13/27 (48%) families. The molecular diagnoses included biallelic variants in SKIV2L, SLC35C1, BRCA1, NSUN2; de novo variants in ARID1B, ARID1A, CREBBP, POGZ, TAF1, HDAC8, and copy-number variation at1p36.11(ARID1A), 8q22.2(VPS13B), Xp22, and Xq13(HDAC8). Variants of unknown significance in known disease genes, and also in genes of uncertain significance, were observed in 7/27 (26%) additional families. Only one gene, HDAC8, could explain the phenotype in more than one family (N = 2). All but two of the genomic diagnoses were for genes discovered, or for conditions recognized, since the introduction of next-generation sequencing. Overall, the DubS-like clinical phenotype is associated with extensive locus heterogeneity and the molecular diagnoses made are for emerging clinical conditions sharing characteristic features that overlap the DubS phenotype | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, N.I.H., Extramural | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a Dubowitz syndrome | |
| 650 | 4 | |a exome sequencing | |
| 650 | 4 | |a genetic heterogeneity | |
| 650 | 4 | |a genome sequencing | |
| 650 | 4 | |a microarray | |
| 650 | 7 | |a Repressor Proteins |2 NLM | |
| 650 | 7 | |a HDAC8 protein, human |2 NLM | |
| 650 | 7 | |a EC 3.5.1.98 |2 NLM | |
| 650 | 7 | |a Histone Deacetylases |2 NLM | |
| 650 | 7 | |a EC 3.5.1.98 |2 NLM | |
| 700 | 1 | |a O'Donnell-Luria, Anne |e verfasserin |4 aut | |
| 700 | 1 | |a Agrawal, Pankaj B |e verfasserin |4 aut | |
| 700 | 1 | |a Coban Akdemir, Zeynep |e verfasserin |4 aut | |
| 700 | 1 | |a Aleck, Kyrieckos A |e verfasserin |4 aut | |
| 700 | 1 | |a Antaki, Danny |e verfasserin |4 aut | |
| 700 | 1 | |a Al Sharhan, Hind |e verfasserin |4 aut | |
| 700 | 1 | |a Au, Ping-Yee B |e verfasserin |4 aut | |
| 700 | 1 | |a Aydin, Hatip |e verfasserin |4 aut | |
| 700 | 1 | |a Beggs, Alan H |e verfasserin |4 aut | |
| 700 | 1 | |a Bilguvar, Kaya |e verfasserin |4 aut | |
| 700 | 1 | |a Boerwinkle, Eric |e verfasserin |4 aut | |
| 700 | 1 | |a Brand, Harrison |e verfasserin |4 aut | |
| 700 | 1 | |a Brownstein, Catherine A |e verfasserin |4 aut | |
| 700 | 1 | |a Buyske, Steve |e verfasserin |4 aut | |
| 700 | 1 | |a Chodirker, Bernard |e verfasserin |4 aut | |
| 700 | 1 | |a Choi, Jungmin |e verfasserin |4 aut | |
| 700 | 1 | |a Chudley, Albert E |e verfasserin |4 aut | |
| 700 | 1 | |a Clericuzio, Carol L |e verfasserin |4 aut | |
| 700 | 1 | |a Cox, Gerald F |e verfasserin |4 aut | |
| 700 | 1 | |a Curry, Cynthia |e verfasserin |4 aut | |
| 700 | 1 | |a de Boer, Elke |e verfasserin |4 aut | |
| 700 | 1 | |a de Vries, Bert B A |e verfasserin |4 aut | |
| 700 | 1 | |a Dunn, Kathryn |e verfasserin |4 aut | |
| 700 | 1 | |a Dutmer, Cullen M |e verfasserin |4 aut | |
| 700 | 1 | |a England, Eleina M |e verfasserin |4 aut | |
| 700 | 1 | |a Fahrner, Jill A |e verfasserin |4 aut | |
| 700 | 1 | |a Geckinli, Bilgen B |e verfasserin |4 aut | |
| 700 | 1 | |a Genetti, Casie A |e verfasserin |4 aut | |
| 700 | 1 | |a Gezdirici, Alper |e verfasserin |4 aut | |
| 700 | 1 | |a Gibson, William T |e verfasserin |4 aut | |
| 700 | 1 | |a Gleeson, Joseph G |e verfasserin |4 aut | |
| 700 | 1 | |a Greenberg, Cheryl R |e verfasserin |4 aut | |
| 700 | 1 | |a Hall, April |e verfasserin |4 aut | |
| 700 | 1 | |a Hamosh, Ada |e verfasserin |4 aut | |
| 700 | 1 | |a Hartley, Taila |e verfasserin |4 aut | |
| 700 | 1 | |a Jhangiani, Shalini N |e verfasserin |4 aut | |
| 700 | 1 | |a Karaca, Ender |e verfasserin |4 aut | |
| 700 | 1 | |a Kernohan, Kristin |e verfasserin |4 aut | |
| 700 | 1 | |a Lauzon, Julie L |e verfasserin |4 aut | |
| 700 | 1 | |a Lewis, M E Suzanne |e verfasserin |4 aut | |
| 700 | 1 | |a Lowry, R Brian |e verfasserin |4 aut | |
| 700 | 1 | |a López-Giráldez, Francesc |e verfasserin |4 aut | |
| 700 | 1 | |a Matise, Tara C |e verfasserin |4 aut | |
| 700 | 1 | |a McEvoy-Venneri, Jennifer |e verfasserin |4 aut | |
| 700 | 1 | |a McInnes, Brenda |e verfasserin |4 aut | |
| 700 | 1 | |a Mhanni, Aziz |e verfasserin |4 aut | |
| 700 | 1 | |a Garcia Minaur, Sixto |e verfasserin |4 aut | |
| 700 | 1 | |a Moilanen, Jukka |e verfasserin |4 aut | |
| 700 | 1 | |a Nguyen, An |e verfasserin |4 aut | |
| 700 | 1 | |a Nowaczyk, Malgorzata J M |e verfasserin |4 aut | |
| 700 | 1 | |a Posey, Jennifer E |e verfasserin |4 aut | |
| 700 | 1 | |a Õunap, Katrin |e verfasserin |4 aut | |
| 700 | 1 | |a Pehlivan, Davut |e verfasserin |4 aut | |
| 700 | 1 | |a Pajusalu, Sander |e verfasserin |4 aut | |
| 700 | 1 | |a Penney, Lynette S |e verfasserin |4 aut | |
| 700 | 1 | |a Poterba, Timothy |e verfasserin |4 aut | |
| 700 | 1 | |a Prontera, Paolo |e verfasserin |4 aut | |
| 700 | 1 | |a Doriqui, Maria Juliana Rodovalho |e verfasserin |4 aut | |
| 700 | 1 | |a Sawyer, Sarah L |e verfasserin |4 aut | |
| 700 | 1 | |a Sobreira, Nara |e verfasserin |4 aut | |
| 700 | 1 | |a Stanley, Valentina |e verfasserin |4 aut | |
| 700 | 1 | |a Torun, Deniz |e verfasserin |4 aut | |
| 700 | 1 | |a Wargowski, David |e verfasserin |4 aut | |
| 700 | 1 | |a Witmer, P Dane |e verfasserin |4 aut | |
| 700 | 1 | |a Wong, Isaac |e verfasserin |4 aut | |
| 700 | 1 | |a Xing, Jinchuan |e verfasserin |4 aut | |
| 700 | 1 | |a Zaki, Maha S |e verfasserin |4 aut | |
| 700 | 1 | |a Zhang, Yeting |e verfasserin |4 aut | |
| 700 | 0 | |a Care4Rare Consortium |e verfasserin |4 aut | |
| 700 | 0 | |a Centers for Mendelian Genomics |e verfasserin |4 aut | |
| 700 | 1 | |a Boycott, Kym M |e verfasserin |4 aut | |
| 700 | 1 | |a Bamshad, Michael J |e verfasserin |4 aut | |
| 700 | 1 | |a Nickerson, Deborah A |e verfasserin |4 aut | |
| 700 | 1 | |a Blue, Elizabeth E |e verfasserin |4 aut | |
| 700 | 1 | |a Innes, A Micheil |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t American journal of medical genetics. Part A |d 2003 |g 185(2021), 1 vom: 01. Jan., Seite 119-133 |w (DE-627)NLM122607996 |x 1552-4833 |7 nnns |
| 773 | 1 | 8 | |g volume:185 |g year:2021 |g number:1 |g day:01 |g month:01 |g pages:119-133 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1002/ajmg.a.61926 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 185 |j 2021 |e 1 |b 01 |c 01 |h 119-133 | ||